Target intelligence / Profile preview

Beta-glucan pattern recognition receptor (β-glucan PRR) (β-glucan PRR)

Target
β-glucan PRR
Molecular classification
Pattern recognition receptor, C-type lectin receptor, Receptor
01

Overview

Beta-glucan pattern recognition receptors (PRRs) are a specialized class of immune receptors, with Dectin-1 (CLEC7A) being the most prominent member, that specifically recognize and bind to β-glucans found in fungal and bacterial cell walls (UniProt: Q9BXN2). These receptors are primarily expressed on myeloid cells, including macrophages, dendritic cells, and neutrophils, where they play a critical role in the innate immune system's ability to detect pathogens (PubMed: 16751776). Upon ligand binding, these receptors initiate signaling cascades involving the Syk kinase and CARD9 adapter protein, resulting in phagocytosis, respiratory burst, and the secretion of cytokines like IL-6 and IL-23 (PubMed: 19536192). In the context of disease, they are vital for defense against fungal infections and have been explored as targets for cancer immunotherapy to "re-educate" the immune system to attack tumor cells (PubMed: 21978437). Therapeutic strategies often involve using β-glucan polymers as agonists to enhance immune surveillance or modulate inflammatory responses in conditions like inflammatory bowel disease (PubMed: 28515777). These receptors also cooperate with other PRRs, such as Toll-like receptors, to fine-tune the immune response (PubMed: 12501250).

Other names
Beta-glucan receptorDectin-1C-type lectin domain family 7 member ACLEC7AComplement receptor 3CR3CD11b/CD18Lactosylceramide receptorScavenger receptor
02

Mechanism of action

Agonistic binding to the receptor (primarily Dectin-1) triggers intracellular signaling via the Syk-CARD9 pathway, leading to the activation of NF-κB and the production of pro-inflammatory cytokines and reactive oxygen species to enhance host defense or anti-tumor immunity (PubMed: 19536192, PubMed: 21978437).

03

Biological functions

Immune responsePhagocytosisSignal transductionCytokine productionAntigen presentationTh17 cell differentiation
04

Disease associations

InfectionCancerInflammationAutoimmune diseaseInflammatory bowel disease
05

Safety considerations

Excessive inflammationCytokine release syndromePotential for autoimmune exacerbationTh17-mediated tissue damage
06

Interacting drugs

Lentinan

5 more in the full profile.

07

Biomarkers

Dectin-1 expressionIL-17 levelsIL-23 levelsSyk phosphorylationAnti-beta-glucan antibody titers

Beyond the preview

Go deeper on Beta-glucan pattern recognition receptor (β-glucan PRR) (β-glucan PRR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-glucan pattern recognition receptor (β-glucan PRR) (β-glucan PRR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call